Edgewise Therapeutics Inc (EWTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 158,832 | 114,357 | 71,658 | 43,215 | 17,192 |
| Operating Income | -158,832 | -114,357 | -71,658 | -43,215 | -17,192 |
| Other Income | 25,019 | 14,194 | 4,018 | 402 | 69 |
| Pre-tax Income | -133,813 | -100,163 | -67,640 | -42,813 | -17,123 |
| Net Income Continuous | -133,813 | -100,163 | -67,640 | -42,813 | -17,123 |
| Net Income | $-133,813 | $-100,163 | $-67,640 | $-42,813 | $-17,123 |
| EPS Basic Total Ops | -1.45 | -1.57 | -1.26 | -1.14 | -23.17 |
| EPS Basic Continuous Ops | -1.45 | -1.57 | -1.26 | -1.14 | -23.17 |
| EPS Diluted Total Ops | -1.45 | -1.57 | -1.26 | -1.14 | -23.17 |
| EPS Diluted Continuous Ops | -1.45 | -1.57 | -1.26 | -1.14 | -23.17 |
| EPS Diluted Before Non-Recurring Items | -1.45 | -1.57 | -1.27 | -1.14 | N/A |
| EBITDA(a) | $-169,087 | $-122,142 | $-71,663 | $-42,943 | $-17,007 |